http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2019, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 10 Sep 2019 09:25:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++D++++++++++ICO+THERAPEUTICS+INC+++++++++++++++++/15900272.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++D++++++++++ICO+THERAPEUTICS+INC+++++++++++++++++/15900272.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++D++++++++++ICO+THERAPEUTICS+INC+++++++++++++++++/15900272.html Tue, 10 Sep 2019 09:25:00 -0400 ICO ICOTF http://www.streetinsider.com/SEC+Filings/Form++D++++++++++ICO+THERAPEUTICS+INC+++++++++++++++++/15900272.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++D++++++++++ICO+THERAPEUTICS+INC+++++++++++++++++/15900272.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++D++++++++++ICO+THERAPEUTICS+INC+++++++++++++++++/15900272.html Tue, 10 Sep 2019 09:25:00 -0400 ICO ICOTF http://www.streetinsider.com/SEC+Filings/Form++D++++++++++ICO+THERAPEUTICS+INC+++++++++++++++++/15237723.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++D++++++++++ICO+THERAPEUTICS+INC+++++++++++++++++/15237723.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++D++++++++++ICO+THERAPEUTICS+INC+++++++++++++++++/15237723.html Fri, 08 Mar 2019 16:13:00 -0400 ICO ICOTF http://www.streetinsider.com/SEC+Filings/Form++D++++++++++ICO+THERAPEUTICS+INC+++++++++++++++++/15237723.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++D++++++++++ICO+THERAPEUTICS+INC+++++++++++++++++/15237723.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++D++++++++++ICO+THERAPEUTICS+INC+++++++++++++++++/15237723.html Fri, 08 Mar 2019 16:13:00 -0400 ICO ICOTF http://www.streetinsider.com/Press+Releases/C+O+R+R+E+C+T+I+O+N+from+Source+--+iCo+Therapeutics+Inc./11106079.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/C+O+R+R+E+C+T+I+O+N+from+Source+--+iCo+Therapeutics+Inc./11106079.html for the full story. http://www.streetinsider.com/Press+Releases/C+O+R+R+E+C+T+I+O+N+from+Source+--+iCo+Therapeutics+Inc./11106079.html Tue, 24 Nov 2015 17:00:00 -0400 ICO ICOTF http://www.streetinsider.com/Press+Releases/C+O+R+R+E+C+T+I+O+N+from+Source+--+iCo+Therapeutics+Inc./11106079.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/C+O+R+R+E+C+T+I+O+N+from+Source+--+iCo+Therapeutics+Inc./11106079.html for the full story. http://www.streetinsider.com/Press+Releases/C+O+R+R+E+C+T+I+O+N+from+Source+--+iCo+Therapeutics+Inc./11106079.html Tue, 24 Nov 2015 17:00:00 -0400 ICO ICOTF http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Third+Quarter+2015+Financial+Results/11105613.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Third+Quarter+2015+Financial+Results/11105613.html for the full story. http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Third+Quarter+2015+Financial+Results/11105613.html Tue, 24 Nov 2015 17:00:00 -0400 ICO ICOTF http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Third+Quarter+2015+Financial+Results/11105613.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Third+Quarter+2015+Financial+Results/11105613.html for the full story. http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Third+Quarter+2015+Financial+Results/11105613.html Tue, 24 Nov 2015 17:00:00 -0400 ICO ICOTF http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Second+Quarter+2015+Financial+Results/10846318.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Second+Quarter+2015+Financial+Results/10846318.html for the full story. http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Second+Quarter+2015+Financial+Results/10846318.html Wed, 26 Aug 2015 17:00:00 -0400 ICO ICOTF http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Second+Quarter+2015+Financial+Results/10846318.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Second+Quarter+2015+Financial+Results/10846318.html for the full story. http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Second+Quarter+2015+Financial+Results/10846318.html Wed, 26 Aug 2015 17:00:00 -0400 ICO ICOTF http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Signs+License+%26amp%3B+Research+Agreement+for+AmiKet%E2%84%A2+Nano/10684396.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Signs+License+%26amp%3B+Research+Agreement+for+AmiKet%E2%84%A2+Nano/10684396.html for the full story. http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Signs+License+%26amp%3B+Research+Agreement+for+AmiKet%E2%84%A2+Nano/10684396.html Mon, 29 Jun 2015 08:00:00 -0400 A.19256546 ICO ICOTF IMNP http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Signs+License+%26amp%3B+Research+Agreement+for+AmiKet%E2%84%A2+Nano/10684396.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Signs+License+%26amp%3B+Research+Agreement+for+AmiKet%E2%84%A2+Nano/10684396.html for the full story. http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Signs+License+%26amp%3B+Research+Agreement+for+AmiKet%E2%84%A2+Nano/10684396.html Mon, 29 Jun 2015 08:00:00 -0400 A.19256546 ICO ICOTF IMNP http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Signs+License+%26amp%3B+Research+Agreement+for+AmiKet%E2%84%A2+Nano/10684396.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Signs+License+%26amp%3B+Research+Agreement+for+AmiKet%E2%84%A2+Nano/10684396.html for the full story. http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Signs+License+%26amp%3B+Research+Agreement+for+AmiKet%E2%84%A2+Nano/10684396.html Mon, 29 Jun 2015 08:00:00 -0400 A.19256546 ICO ICOTF IMNP http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Signs+License+%26amp%3B+Research+Agreement+for+AmiKet%E2%84%A2+Nano/10684396.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Signs+License+%26amp%3B+Research+Agreement+for+AmiKet%E2%84%A2+Nano/10684396.html for the full story. http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Signs+License+%26amp%3B+Research+Agreement+for+AmiKet%E2%84%A2+Nano/10684396.html Mon, 29 Jun 2015 08:00:00 -0400 A.19256546 ICO ICOTF IMNP http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Voting+%26amp%3B+Election+Results+from+Annual+Meeting+of+Shareholders/10682633.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Voting+%26amp%3B+Election+Results+from+Annual+Meeting+of+Shareholders/10682633.html for the full story. http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Voting+%26amp%3B+Election+Results+from+Annual+Meeting+of+Shareholders/10682633.html Fri, 26 Jun 2015 16:00:00 -0400 ICO ICOTF http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Voting+%26amp%3B+Election+Results+from+Annual+Meeting+of+Shareholders/10682633.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Voting+%26amp%3B+Election+Results+from+Annual+Meeting+of+Shareholders/10682633.html for the full story. http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+Voting+%26amp%3B+Election+Results+from+Annual+Meeting+of+Shareholders/10682633.html Fri, 26 Jun 2015 16:00:00 -0400 ICO ICOTF http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Initiates+Phase+II+Clinical+Trials+With+Bertilimumab+In+Ulcerative+Colitis+And+Bullous+Pemphigoid/10680396.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Initiates+Phase+II+Clinical+Trials+With+Bertilimumab+In+Ulcerative+Colitis+And+Bullous+Pemphigoid/10680396.html for the full story. http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Initiates+Phase+II+Clinical+Trials+With+Bertilimumab+In+Ulcerative+Colitis+And+Bullous+Pemphigoid/10680396.html Thu, 25 Jun 2015 16:30:00 -0400 A.19256546 ICO ICOTF IMNP http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Initiates+Phase+II+Clinical+Trials+With+Bertilimumab+In+Ulcerative+Colitis+And+Bullous+Pemphigoid/10680396.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Initiates+Phase+II+Clinical+Trials+With+Bertilimumab+In+Ulcerative+Colitis+And+Bullous+Pemphigoid/10680396.html for the full story. http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Initiates+Phase+II+Clinical+Trials+With+Bertilimumab+In+Ulcerative+Colitis+And+Bullous+Pemphigoid/10680396.html Thu, 25 Jun 2015 16:30:00 -0400 A.19256546 ICO ICOTF IMNP http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Initiates+Phase+II+Clinical+Trials+With+Bertilimumab+In+Ulcerative+Colitis+And+Bullous+Pemphigoid/10680396.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Initiates+Phase+II+Clinical+Trials+With+Bertilimumab+In+Ulcerative+Colitis+And+Bullous+Pemphigoid/10680396.html for the full story. http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Initiates+Phase+II+Clinical+Trials+With+Bertilimumab+In+Ulcerative+Colitis+And+Bullous+Pemphigoid/10680396.html Thu, 25 Jun 2015 16:30:00 -0400 A.19256546 ICO ICOTF IMNP http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Initiates+Phase+II+Clinical+Trials+With+Bertilimumab+In+Ulcerative+Colitis+And+Bullous+Pemphigoid/10680396.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Initiates+Phase+II+Clinical+Trials+With+Bertilimumab+In+Ulcerative+Colitis+And+Bullous+Pemphigoid/10680396.html for the full story. http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Initiates+Phase+II+Clinical+Trials+With+Bertilimumab+In+Ulcerative+Colitis+And+Bullous+Pemphigoid/10680396.html Thu, 25 Jun 2015 16:30:00 -0400 A.19256546 ICO ICOTF IMNP http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Expands+Immuno-Dermatology+Development+Portfolio+With+Topical+Nano-Formulated+Cyclosporine+A/10639962.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Expands+Immuno-Dermatology+Development+Portfolio+With+Topical+Nano-Formulated+Cyclosporine+A/10639962.html for the full story. http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Expands+Immuno-Dermatology+Development+Portfolio+With+Topical+Nano-Formulated+Cyclosporine+A/10639962.html Wed, 10 Jun 2015 08:00:00 -0400 A.19256546 ICO ICOTF IMNP http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Expands+Immuno-Dermatology+Development+Portfolio+With+Topical+Nano-Formulated+Cyclosporine+A/10639962.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Expands+Immuno-Dermatology+Development+Portfolio+With+Topical+Nano-Formulated+Cyclosporine+A/10639962.html for the full story. http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Expands+Immuno-Dermatology+Development+Portfolio+With+Topical+Nano-Formulated+Cyclosporine+A/10639962.html Wed, 10 Jun 2015 08:00:00 -0400 A.19256546 ICO ICOTF IMNP http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Expands+Immuno-Dermatology+Development+Portfolio+With+Topical+Nano-Formulated+Cyclosporine+A/10639962.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Expands+Immuno-Dermatology+Development+Portfolio+With+Topical+Nano-Formulated+Cyclosporine+A/10639962.html for the full story. http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Expands+Immuno-Dermatology+Development+Portfolio+With+Topical+Nano-Formulated+Cyclosporine+A/10639962.html Wed, 10 Jun 2015 08:00:00 -0400 A.19256546 ICO ICOTF IMNP http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Expands+Immuno-Dermatology+Development+Portfolio+With+Topical+Nano-Formulated+Cyclosporine+A/10639962.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Expands+Immuno-Dermatology+Development+Portfolio+With+Topical+Nano-Formulated+Cyclosporine+A/10639962.html for the full story. http://www.streetinsider.com/Press+Releases/Immune+Pharmaceuticals+Expands+Immuno-Dermatology+Development+Portfolio+With+Topical+Nano-Formulated+Cyclosporine+A/10639962.html Wed, 10 Jun 2015 08:00:00 -0400 A.19256546 ICO ICOTF IMNP http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+First+Quarter+2015+Financial+Results/10605429.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+First+Quarter+2015+Financial+Results/10605429.html for the full story. http://www.streetinsider.com/Press+Releases/iCo+Therapeutics+Announces+First+Quarter+2015+Financial+Results/10605429.html Thu, 28 May 2015 17:00:00 -0400 ICO ICOTF